Home Markets InflaRx stock soars after positive Phase 2a data for INF904 drug

InflaRx stock soars after positive Phase 2a data for INF904 drug

Nov 10, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/inflarx-stock-soars-after-positive-phase-2a-data-for-inf904-drug-93CH-4345710

You May Also Like

U.S. stock futures flat amid Iran, rate caution; Broadcom dips after earnings

New Jersey takes fight over Kalshi’s prediction market to US Supreme Court

From hunger to obesity: Developing world faces growing threat to child health

Broadcom forecasts quarterly revenue below estimates

HPE raises annual forecasts as AI, networking demand lifts quarterly revenue

Pet food platform Golden Pet Brands taps banks for IPO, sources say